2017
DOI: 10.1590/1806-9282.63.06.488
|View full text |Cite
|
Sign up to set email alerts
|

Thrombosed aneurysm of saphenous vein coronary artery bypass grafting

Abstract: We describe the case of a male patient, aged 76 years, referred for cardiac investigation due to retrosternal chest pain and dyspnea. He had a history of acute myocardial infarction and angioplasties in the last 30 years, including a saphenous vein coronary artery bypass grafting (SVCABG). Echocardiogram showed hypoechoic oval formation near the right ventricle, suggesting a pericardial cyst. Computed angiotomography revealed a predominantly fusiform and thrombosed aneurysmal dilation of the SVCABG to the righ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…The GSV is a small-sized thick-walled vein, thus it has been frequently used as an arterial substitute for CABG for a long period [ 6 ]. Very long patency of patent CABG with a GSV graft has been reported [ 7 ], but there was a potential risk of aneurysm and pseudoaneurysm after the CABG using GSV grafts [ 8 , 9 ]. The present case underwent retransplantation due to chronic rejection 8 years after LDLT, in which the GSV conduit was patent without any vascular complications throughout the 8-year period.…”
Section: Discussionmentioning
confidence: 99%
“…The GSV is a small-sized thick-walled vein, thus it has been frequently used as an arterial substitute for CABG for a long period [ 6 ]. Very long patency of patent CABG with a GSV graft has been reported [ 7 ], but there was a potential risk of aneurysm and pseudoaneurysm after the CABG using GSV grafts [ 8 , 9 ]. The present case underwent retransplantation due to chronic rejection 8 years after LDLT, in which the GSV conduit was patent without any vascular complications throughout the 8-year period.…”
Section: Discussionmentioning
confidence: 99%